Tailoring chemoimmunotherapy de-escalation in early-stage triple-negative breast cancer. Goncalves A, de Nonneville A. Lancet Oncol 2025;26:273-274.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Goncalves A, de Nonneville A. Tailoring chemoimmunotherapy de-escalation in early-stage triple-negative breast cancer. Lancet Oncol 2025;26:273-274.
PMID: 40049192